Dr. Alvarez-Breckenridge is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 Holcombe Boulevard
Room FC7.2000, Unit 442
Houston, TX 77030Phone+1 614-747-0723
Summary
- Christopher Alvarez-Breckenridge, M.D., Ph.D., is an assistant professor within MD Anderson Cancer Center’s Department of Neurosurgery with expertise in spinal tumors, particularly metastatic disease and immunotherapy. He was a member of the Medical Scientist Training Program (MSTP) at The Ohio State University where he received his combined M.D./Ph.D., and his doctoral research focused on oncolytic viral therapy for gliomas. He subsequently completed residency in neurosurgery at Massachusetts General Hospital. During that time, he was awarded the Massachusetts General Hospital Neurosurgery Research Award and the American Association of Neurological Surgeons Journal of Neuro-Oncology Award for his research on immunotherapy for brain metastases and leptomeningeal disease. Dr. Alvarez-Breckenridge became a fellow in Neurosurgical Oncology at The University of Texas MD Anderson Cancer Center in 2020 where he worked and learned alongside experts within the institution. His surgical practice focuses on tumors of the spine, and he is eager to build upon his prior research experiences to develop an immuno-oncology focused translational research program.
Education & Training
- Massachusetts General HospitalResidency, Neurological Surgery, 2013 - 2020
- Ohio State University College of MedicineClass of 2013
Certifications & Licensure
- FL State Medical License 2021 - Present
- TX State Medical License 2020 - 2025
- MA State Medical License 2013 - 2021
Awards, Honors, & Recognition
- Early Clinical Investigator Award Cancer Prevention & Research Institute of Texas (CPRIT), 2022
- Arthur and Sandra Irving Cancer Immunology Symposium Promising Young Scientist Massachusetts General Hospital, 2022
- Physician-Scientist Program MD Anderson Cancer Center, 2022
- Join now to see all
Publications & Presentations
PubMed
- Thrombosis, brain metastasis formation, and the perivascular metastatic niche-Novel insights from the tumor microvascular circulation.Christopher Alvarez-Breckenridge, Priscilla K Brastianos, Daniel P Cahill
Neuro-Oncology. 2024-11-04 - Spinal laser interstitial thermal therapy and radiotherapy for thoracic metastatic epidural spinal cord compression.Martin C Tom, Suraj Komatineni, Chenyang Wang, Romulo A Andrade de Almeida, Amol J Ghia
Journal of Neuro-Oncology. 2024-11-01 - Antiangiogenic Tyrosine Kinase Inhibitors have Differential Efficacy in Clear Cell Renal Cell Carcinoma in Bone.Stefan Maksimovic, Nina C Boscolo, Ludovica La Posta, Sergio Barrios, Mohammad Jad Moussa
Cancer Research Communications. 2024-10-01
Press Mentions
- CPRIT Awards $2.5 Million to Support MD Anderson Cancer ResearchSeptember 14th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: